Disclosure Of Fair Value Measurement [Text Block]

Cinclus Pharma Holding AB - Filing #5879290

Concept	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Disclosure of fair value measurement [text block]		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	—	—	—	601 013 SEK	—	—	—	—	—	—	94 413 SEK	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities	—	—	—	45 683 SEK	—	—	—	—	—	—	171 213 SEK	—	—	—	—	—
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	—	771 997 SEK	1 297 740 SEK	555 330 SEK	920,000 SEK	28 667 SEK	509,000 SEK	26 004 SEK	606 837 SEK	503 524 SEK	76 800 SEK	126 874 SEK	509,000 SEK	16 837 SEK	394 163 SEK	503 691 SEK
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]